Oramed Pharmaceuticals, Inc

-0.41 (-2.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)716.42M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.97 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$21.01
50-Day MA$23.48
200-Day MA$15.55
See more pivots

Oramed Pharmaceuticals, Inc Stock, NASDAQ:ORMP

1185 Avenue of the Americas, 3rd Floor, New York, New York 10019
United States of America
Phone: +1.844.967.2633
Number of Employees: 13


Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.